Patent: 6,627,615
✉ Email this page to a colleague
Summary for Patent: 6,627,615
| Title: | Methods and compositions for in vivo gene therapy |
| Abstract: | Novel methods and compositions are provided for introducing a gene capable of modulating the genotype and phenotype into two or more tissues following systemic administration. The gene can be introduced into a mammalian host by way of an expression vector either as naked DNA or associated with lipid carriers, particularly cationic lipid carriers. Multiple individual tisssues can be transfected using naked DNA. Using a DNA: lipid carrier complex. multiple tissues and cell types can be transfected. The techniques and compositions find use in the palliation or treatment of any of a variety of genetic-based disorders. |
| Inventor(s): | Debs; Robert J. (Mill Valley, CA), Zhu; Ning (El Cerrito, CA) |
| Assignee: | The Regents of the University of California (Oakland, CA) |
| Application Number: | 09/132,391 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,627,615
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | June 04, 1986 | ⤷ Sign Up | 2011-12-17 |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Sign Up | 2011-12-17 | |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Sign Up | 2011-12-17 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
